-
1
-
-
67349151349
-
Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders
-
Valent P, (2009) Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders. Blood Rev 23: 157-165.
-
(2009)
Blood Rev
, vol.23
, pp. 157-165
-
-
Valent, P.1
-
3
-
-
77954143319
-
Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence
-
Crane MM, Chang CM, Kobayashi MG, Weller PF, (2010) Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence. J Allergy Clin Immunol 126: 179-181.
-
(2010)
J Allergy Clin Immunol
, vol.126
, pp. 179-181
-
-
Crane, M.M.1
Chang, C.M.2
Kobayashi, M.G.3
Weller, P.F.4
-
4
-
-
37548999803
-
Mechanisms for the proliferation of eosinophilic leukemia cells by FIP1L1-PDGFRalpha
-
Ishihara K, Kitamura H, Hiraizumi K, Kaneko M, Takahashi A, et al. (2008) Mechanisms for the proliferation of eosinophilic leukemia cells by FIP1L1-PDGFRalpha. Biochem Biophys Res Commun 366: 1007-1011.
-
(2008)
Biochem Biophys Res Commun
, vol.366
, pp. 1007-1011
-
-
Ishihara, K.1
Kitamura, H.2
Hiraizumi, K.3
Kaneko, M.4
Takahashi, A.5
-
5
-
-
77954089699
-
Refining the definition of hypereosinophilic syndrome
-
Simon HU, Rothenberg ME, Bochner BS, Weller PF, Wardlaw AJ, et al. (2010) Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol 126: 45-49.
-
(2010)
J Allergy Clin Immunol
, vol.126
, pp. 45-49
-
-
Simon, H.U.1
Rothenberg, M.E.2
Bochner, B.S.3
Weller, P.F.4
Wardlaw, A.J.5
-
6
-
-
75749119699
-
Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update
-
Tefferi A, Gotlib J, Pardanani A, (2010) Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update. Mayo Clin Proc 85: 158-164.
-
(2010)
Mayo Clin Proc
, vol.85
, pp. 158-164
-
-
Tefferi, A.1
Gotlib, J.2
Pardanani, A.3
-
7
-
-
0344987881
-
A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome
-
Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, et al. (2003) A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348: 1201-1214.
-
(2003)
N Engl J Med
, vol.348
, pp. 1201-1214
-
-
Cools, J.1
DeAngelo, D.J.2
Gotlib, J.3
Stover, E.H.4
Legare, R.D.5
-
8
-
-
0022360099
-
Establishment and characterization of a new human eosinophilic leukemia cell line
-
Saito H, Bourinbaiar A, Ginsburg M, Minato K, Ceresi E, et al. (1985) Establishment and characterization of a new human eosinophilic leukemia cell line. Blood 66: 1233-1240.
-
(1985)
Blood
, vol.66
, pp. 1233-1240
-
-
Saito, H.1
Bourinbaiar, A.2
Ginsburg, M.3
Minato, K.4
Ceresi, E.5
-
9
-
-
40949147830
-
A single weekly dose of imatinib is sufficient to induce and maintain remission of chronic eosinophilic leukaemia in FIP1L1-PDGFRA-expressing patients
-
Helbig G, Stella-Holowiecka B, Majewski M, Calbecka M, Gajkowska J, et al. (2008) A single weekly dose of imatinib is sufficient to induce and maintain remission of chronic eosinophilic leukaemia in FIP1L1-PDGFRA-expressing patients. Br J Haematol 141: 200-204.
-
(2008)
Br J Haematol
, vol.141
, pp. 200-204
-
-
Helbig, G.1
Stella-Holowiecka, B.2
Majewski, M.3
Calbecka, M.4
Gajkowska, J.5
-
10
-
-
1642324059
-
The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia
-
Cools J, Quentmeier H, Huntly BJ, Marynen P, Griffin JD, et al. (2004) The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia. Blood 103: 2802-2805.
-
(2004)
Blood
, vol.103
, pp. 2802-2805
-
-
Cools, J.1
Quentmeier, H.2
Huntly, B.J.3
Marynen, P.4
Griffin, J.D.5
-
11
-
-
46749115588
-
Ki11502, a novel multitargeted receptor tyrosine kinase inhibitor, induces growth arrest and apoptosis of human leukemia cells in vitro and in vivo
-
Nishioka C, Ikezoe T, Yang J, Miwa A, Tasaka T, et al. (2008) Ki11502, a novel multitargeted receptor tyrosine kinase inhibitor, induces growth arrest and apoptosis of human leukemia cells in vitro and in vivo. Blood 111: 5086-5092.
-
(2008)
Blood
, vol.111
, pp. 5086-5092
-
-
Nishioka, C.1
Ikezoe, T.2
Yang, J.3
Miwa, A.4
Tasaka, T.5
-
12
-
-
23844464445
-
Transplantation of human acute myeloid leukemia (AML) cells in immunodeficient mice reveals altered cell surface phenotypes and expression of human endothelial markers
-
Henschler R, Gottig S, Junghahn I, Bug G, Seifried E, et al. (2005) Transplantation of human acute myeloid leukemia (AML) cells in immunodeficient mice reveals altered cell surface phenotypes and expression of human endothelial markers. Leuk Res 29: 1191-1199.
-
(2005)
Leuk Res
, vol.29
, pp. 1191-1199
-
-
Henschler, R.1
Gottig, S.2
Junghahn, I.3
Bug, G.4
Seifried, E.5
-
13
-
-
0034544938
-
Anti-CD7 antibody and immunotoxin treatment of human CD7(+)T-cell leukaemia is significantly less effective in NOD/LtSz-scid mice than in CB.17 scid mice
-
Flavell DJ, Warnes SL, Noss AL, Flavell SU, (2000) Anti-CD7 antibody and immunotoxin treatment of human CD7(+)T-cell leukaemia is significantly less effective in NOD/LtSz-scid mice than in CB.17 scid mice. Br J Cancer 83: 1755-1761.
-
(2000)
Br J Cancer
, vol.83
, pp. 1755-1761
-
-
Flavell, D.J.1
Warnes, S.L.2
Noss, A.L.3
Flavell, S.U.4
-
14
-
-
77956649599
-
Structural resemblances and comparisons of the relative pharmacological properties of imatinib and nilotinib
-
Manley PW, Stiefl N, Cowan-Jacob SW, Kaufman S, Mestan J, et al. (2010) Structural resemblances and comparisons of the relative pharmacological properties of imatinib and nilotinib. Bioorg Med Chem 18: 6977-6986.
-
(2010)
Bioorg Med Chem
, vol.18
, pp. 6977-6986
-
-
Manley, P.W.1
Stiefl, N.2
Cowan-Jacob, S.W.3
Kaufman, S.4
Mestan, J.5
-
15
-
-
34548822673
-
AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo
-
Yang J, Ikezoe T, Nishioka C, Tasaka T, Taniguchi A, et al. (2007) AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo. Blood 110: 2034-2040.
-
(2007)
Blood
, vol.110
, pp. 2034-2040
-
-
Yang, J.1
Ikezoe, T.2
Nishioka, C.3
Tasaka, T.4
Taniguchi, A.5
-
16
-
-
77953628107
-
Successful treatment of imatinib-resistant hypereosinophilic syndrome with nilotinib
-
Ikezoe T, Togitani K, Tasaka T, Nishioka C, Yokoyama A, (2010) Successful treatment of imatinib-resistant hypereosinophilic syndrome with nilotinib. Leuk Res 34: e200-201.
-
(2010)
Leuk Res
, vol.34
-
-
Ikezoe, T.1
Togitani, K.2
Tasaka, T.3
Nishioka, C.4
Yokoyama, A.5
-
17
-
-
66849087150
-
FIP1L1-PDGFRalpha D842V, a novel panresistant mutant, emerging after treatment of FIP1L1-PDGFRalpha T674I eosinophilic leukemia with single agent sorafenib
-
Lierman E, Michaux L, Beullens E, Pierre P, Marynen P, et al. (2009) FIP1L1-PDGFRalpha D842V, a novel panresistant mutant, emerging after treatment of FIP1L1-PDGFRalpha T674I eosinophilic leukemia with single agent sorafenib. Leukemia 23: 845-851.
-
(2009)
Leukemia
, vol.23
, pp. 845-851
-
-
Lierman, E.1
Michaux, L.2
Beullens, E.3
Pierre, P.4
Marynen, P.5
-
18
-
-
84856830328
-
Low-dose Nilotinib can maintain complete molecular remissions in FIP1L1/PDGFRA-positive hypereosinophilic syndrome
-
Tabouret E, Charbonnier A, Mozziconacci MJ, Ivanov V, (2010) Low-dose Nilotinib can maintain complete molecular remissions in FIP1L1/PDGFRA-positive hypereosinophilic syndrome. Leuk Res.
-
(2010)
Leuk Res
-
-
Tabouret, E.1
Charbonnier, A.2
Mozziconacci, M.J.3
Ivanov, V.4
-
19
-
-
77953258448
-
Clinical characteristics of patients with chronic eosinophilic leukaemia (CEL) harbouring FIP1L1-PDGFRA fusion transcript-results of Polish multicentre study
-
Helbig G, Moskwa A, Hus M, Piszcz J, Swiderska A, et al. (2009) Clinical characteristics of patients with chronic eosinophilic leukaemia (CEL) harbouring FIP1L1-PDGFRA fusion transcript-results of Polish multicentre study. Hematol Oncol 28: 93-97.
-
(2009)
Hematol Oncol
, vol.28
, pp. 93-97
-
-
Helbig, G.1
Moskwa, A.2
Hus, M.3
Piszcz, J.4
Swiderska, A.5
-
20
-
-
0013879504
-
Normal mouse erythropoiesis. I. The role of the spleen in mouse erythropoiesis
-
Brodsky I, Dennis LH, Kahn SB, Brady LW, (1966) Normal mouse erythropoiesis. I. The role of the spleen in mouse erythropoiesis. Cancer Res 26: 198-201.
-
(1966)
Cancer Res
, vol.26
, pp. 198-201
-
-
Brodsky, I.1
Dennis, L.H.2
Kahn, S.B.3
Brady, L.W.4
-
21
-
-
0032783222
-
The role of trisomy 8 in the pathogenesis of chronic eosinophilic leukemia
-
Ma SK, Kwong YL, Shek TW, Wan TS, Chow EY, et al. (1999) The role of trisomy 8 in the pathogenesis of chronic eosinophilic leukemia. Hum Pathol 30: 864-868.
-
(1999)
Hum Pathol
, vol.30
, pp. 864-868
-
-
Ma, S.K.1
Kwong, Y.L.2
Shek, T.W.3
Wan, T.S.4
Chow, E.Y.5
-
22
-
-
33845596263
-
Granulocytic sarcoma: 32 cases and review of the literature
-
Paydas S, Zorludemir S, Ergin M, (2006) Granulocytic sarcoma: 32 cases and review of the literature. Leuk Lymphoma 47: 2527-2541.
-
(2006)
Leuk Lymphoma
, vol.47
, pp. 2527-2541
-
-
Paydas, S.1
Zorludemir, S.2
Ergin, M.3
-
23
-
-
0035191409
-
Granulocytic sarcoma in MLL-positive infant acute myelogenous leukemia: fluorescence in situ hybridization study of childhood acute myelogenous leukemia for detecting MLL rearrangement
-
Park KU, Lee DS, Lee HS, Kim CJ, Cho HI, (2001) Granulocytic sarcoma in MLL-positive infant acute myelogenous leukemia: fluorescence in situ hybridization study of childhood acute myelogenous leukemia for detecting MLL rearrangement. Am J Pathol 159: 2011-2016.
-
(2001)
Am J Pathol
, vol.159
, pp. 2011-2016
-
-
Park, K.U.1
Lee, D.S.2
Lee, H.S.3
Kim, C.J.4
Cho, H.I.5
-
24
-
-
56249123594
-
Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias
-
Gotlib J, Cools J, (2008) Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias. Leukemia 22: 1999-2010.
-
(2008)
Leukemia
, vol.22
, pp. 1999-2010
-
-
Gotlib, J.1
Cools, J.2
-
25
-
-
55949102355
-
Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome: a phase-II study
-
Metzgeroth G, Walz C, Erben P, Popp H, Schmitt-Graeff A, et al. (2008) Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome: a phase-II study. Br J Haematol 143: 707-715.
-
(2008)
Br J Haematol
, vol.143
, pp. 707-715
-
-
Metzgeroth, G.1
Walz, C.2
Erben, P.3
Popp, H.4
Schmitt-Graeff, A.5
-
26
-
-
77952812169
-
Guidelines for the welfare and use of animals in cancer research
-
Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, et al. (2010) Guidelines for the welfare and use of animals in cancer research. Br J Cancer 102: 1555-1577.
-
(2010)
Br J Cancer
, vol.102
, pp. 1555-1577
-
-
Workman, P.1
Aboagye, E.O.2
Balkwill, F.3
Balmain, A.4
Bruder, G.5
-
27
-
-
33847235697
-
Clinically proven markers of metastasis predict metastatic spread of human melanoma cells engrafted in scid mice
-
Thies A, Mauer S, Fodstad O, Schumacher U, (2007) Clinically proven markers of metastasis predict metastatic spread of human melanoma cells engrafted in scid mice. Br J Cancer 96: 609-616.
-
(2007)
Br J Cancer
, vol.96
, pp. 609-616
-
-
Thies, A.1
Mauer, S.2
Fodstad, O.3
Schumacher, U.4
|